Refreshing results…
Resolving therapy resistance mechanisms in multiple myeloma by multiomics subclone analysis
UploadMechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma
UploadA phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma
UploadActin cytoskeleton deregulation confers midostaurin resistance in FLT3-mutant acute myeloid leukemia
Download from www.nature.comDifferent MAF translocations confer similar prognosis in newly diagnosed multiple myeloma patients
UploadMissing publications? Search for publications with a matching author name.